Instrument Inactif

Autres langues Northwest Biotherapeutics, Inc OTC Bulletin Board

Actions

US66737P5017

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

10/05	Northwest Biotherapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
21/03	Northwest Biotherapeutics, Inc. nomme Pat Sarma à son conseil d'administration	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property	17/06
Northwest Biotherapeutics: Q1 Earnings Snapshot	10/05
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	21/03
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	14/03
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification	06/02
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma	22/12
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma	21/12
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma	21/12
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application	22/11
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC	10/11
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)	19/10/23
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application	16/10/23
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application	13/10/23
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE	28/09/23
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)	25/09/23
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)	14/09/23
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)	13/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Northwest Biotherapeutics, Inc OTC Bulletin Board

Actions

US66737P5017

Autres langues

Filtres